Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

Kroken, Rune A.; Johnsen, Erik; Ruud, Torleif; Wentzel-Larsen, Tore; Jørgensen, Hugo A
January 2009
BMC Psychiatry;2009, Vol. 9, Special section p1
Academic Journal
Background: Surveys on prescription patterns for antipsychotics in the Scandinavian public health system are scarce despite the prevalent use of these drugs. The clinical differences between antipsychotic drugs are mainly in the areas of safety and tolerability, and international guidelines for the treatment of schizophrenia offer rational strategies to minimize the burden of side effects related to antipsychotic treatment. The implementation of treatment guidelines in clinical practice have proven difficult to achieve, as reflected by major variations in the prescription patterns of antipsychotics between different comparable regions and countries. The objective of this study was to evaluate the practice of treatment of schizophrenic patients with antipsychotics at discharge from acute inpatient settings at a national level. Methods: Data from 486 discharges of patients from emergency inpatient treatment of schizophrenia were collected during a three-month period in 2005; the data were collected in a large national study that covered 75% of Norwegian hospitals receiving inpatients for acute treatment. Antipsychotic treatment, demographic variables, scores from the Global Assessment of Functioning and Health of the Nation Outcome Scales and information about comorbid conditions and prior treatment were analyzed to seek predictors for nonadherence to guidelines. Results: In 7.6% of the discharges no antipsychotic treatment was given; of the remaining discharges, 35.6% were prescribed antipsychotic polypharmacy and 41.9% were prescribed at least one first-generation antipsychotic (FGA). The mean chlorpromazine equivalent dose was 450 (SD 347, range 25-2800). In the multivariate regression analyses, younger age, previous inpatient treatment in the previous 12 months before index hospitalization, and a comorbid diagnosis of personality disorder or mental retardation predicted antipsychotic polypharmacy, while previous inpatient treatment in the previous 12 months also predicted prescription of at least one FGA. Conclusion: Our national survey of antipsychotic treatment at discharge from emergency inpatient treatment revealed antipsychotic drug regimens that are to some degree at odds with current guidelines, with increased risk of side effects. Patients with high relapse rates, comorbid conditions, and previous inpatient treatment are especially prone to be prescribed antipsychotic drug regimens not supported by international guidelines.


Related Articles

  • Drug induced psychosis with doxazosin. Evans, M.; Perera, P.W. // BMJ: British Medical Journal (International Edition);06/28/97, Vol. 314 Issue 7098, p1869 

    Discusses the side effects of using doxazosin. Absence of evidence that doxazosin leads to psychiatric complications; Case study of elderly woman who recovered from acute psychosis after drug was withdrawn; Medical history of the woman; Treatment regimen.

  • Etanercept.  // Reactions Weekly;7/26/2008, Issue 1212, p16 

    The article describes the case of two patients who developed acute psychosis during treatment with antirheumatic drug etanercept. Etanercept was withdrawn when a 53-year-old man's mental health declined further after the drug has been reinitiated. About 3 years after the drug was started, a...

  • Long-term use of psychiatric drugs: Maudsley debate.  // Reactions Weekly;May2015, Vol. 1552 Issue 1, p8 

    The article discusses the highlights of the 52nd Maudsley debate on mental health services issues including long-term use of psychiatric drugs, held on May 13, 2015, with arguments presented by Professor Peter Gøtzsche and Professional Allan Yong and "Guardian" newspaper writer John Crace.

  • ANTIPSYCHOTICS LEAD TO WEIGHT GAIN IN PEDIATRIC PATIENTS.  // Contemporary Pediatrics;Nov2009, Vol. 26 Issue 11, p11 

    The article discusses research on the link between antipsychotics and weight gain in children. It references a study published in the October 28, 2009 issue of the "Journal of the American Medical Association." The study included 205 pediatric patients diagnosed with mood spectrum, schizophrenia...

  • Antipsychotic regulation in all indications premature?  // Reactions Weekly;5/5/2007, Issue 1150, p5 

    The article discusses research being done on the suggested regulation of antipsychotics for all elderly patients. It references a study by Y. Barak et al published in the April 2007 issue of the "American Journal of Geriatric Psychiatry." According to researchers from Israel, the suggested...

  • Recording adverse drug reactions in a forensic psychiatry unit: how can we improve standards? Gibbon, Simon; Khalifa, Najat // British Journal of Forensic Practice;Aug2005, Vol. 7 Issue 3, p7 

    Adverse drug reactions (ADRs) are increasingly recognised as an important cause of morbidity and mortality. Psychiatric patients, and especially those in forensic units, may be at increased risk of ADRs. Detection and documentation of previous ADRs are essential in reducing the risk of future...

  • Survey backs need for drug monitoring.  // Community Care;4/15/2004, Issue 1518, p10 

    Reports on the percentage of prescription drug users in Scotland who have experienced side-effects according to a Scottish Association of Mental Health survey in 2004. Number of users included in the survey; Requirement for the direct reporting of side-effects of psychiatric drugs.

  • The Conventional Long-acting Antipsychotics. Bhagar, Harpriya A.; Schmetzer, Alan D. // Annals of the American Psychotherapy Association;Spring2006, Vol. 9 Issue 1, p26 

    The article provides information on two conventional antipsychotics, fluphenazine decanoate and haloperidol decanoate. The administration of haldol decanoate is discussed. It stresses the need for patients to be tried on the oral formulation to establish tolerability. The adverse effects of the...

  • Aripiprazole.  // Reactions Weekly;10/28/2006, Issue 1125, p6 

    The article examines the case of a 48-year-old woman who experienced an exacerbation of Parkinson's disease while being treated with aripiprazole for psychosis. The woman experienced worsening psychosis despite increasing dosages of quetiapine and was admitted after a suicide attempt. After...

  • Weight gain. Houltram, Brian; Scanlan, Mike // Nursing Standard;5/26/2004, Vol. 18 Issue 37, p41 

    Describes a care map used by community mental health nurses and patients to manage weight gain, a side effect of atypical antipsychotic drugs. Discussion about the benefits and drawbacks of the medication with patients; Physical conditions associated with excessive weight gain; Need for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics